Atlas Trials

Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer

Clinical trial NCT01024504 · COMPLETED

Trial details

NCT number
NCT01024504
Sponsor
Hellenic Oncology Research Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2006-03-01
Primary completion
2010-03-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.